Changes in elderly women's health-related quality of life following discontinuation of hormone replacement therapy

BMC Women's Health

Volumn 5, Issue , 2005, Pages

  Heller, Debra A ^a,b   Gold, Carol H ^b   Ahern, Frank M ^b   Pringle, Kristine E ^a   Brown, Theresa V ^a   Glessner, Margaret R ^a  

^a Pennsylvania Department of Aging   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HEALTH PROGRAM; HEALTH STATUS; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; PAIN; PHYSICAL ACTIVITY; POSTAL MAIL; PRESCRIPTION; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT WITHDRAWAL;

EID: 26844492087     PISSN: 14726874     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-5-7     Document Type: Article

References (39)

1. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992, 117(12):1016-1037.
2. Stampfer M, Colditz G: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991, 20:47-63.
3. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R et al: Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003, 349(6):523-534.
4. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
5. The Women's Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291(14):1701-1712.
6. U.S. Preventive Services Task Force: Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Int Med 2002, 137(10):834-839.
7. Hersh AL, Stefanick ML, Stafford RS: National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004, 291(1):47-53.
8. Quality of life: key success factor for the individual well-being http://www.novonordisk.com/therapy_areas/hrt/ our_hrt_products/quality_of_life.asp
9. Tosteson AN, Gabriel SE, Kneeland TS, Moncur MM, Manganiello PD, Schiff I, Ettinger B, Melton LJ: Has the impact of hormone replacement therapy on health-related quality of life been undervalued? Journal of Women's Health and Gender-Based Medicine 2000, 9(2):119-130.
10. Olson MB, Merz CNB, Shaw LJ, Mankad S, Reis SE, Pohost GM, Smith KM, McGorray SP, Cornell CE, Kelsey SE: Hormone replacement, race, and psychological health in women: a report from the NHLBI-sponsored WISE study. Journal of Women's Health 2004, 13(3):325-332.
11. Whooley MA, Grady D, Cauley JA: Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med 2000, 15(8):535-541.
12. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA: Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement (HERS) Trial. JAMA 2002, 287(5):591-597.
13. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ et al: Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003, 348(19):1839-1854.
14. Heller DA, Pringle KE, Ahern FM, Brown TV: PACE/PACENET Survey on Health and Well-Being, 2000-2001. In: Report Submitted to the Pennsylvania Department of Aging. Harrisburg, Pennsylvania; 2004.
15. Centers for Disease Control and Prevention: Measuring healthy days. Atlanta, Georgia; 2000.
16. Testa M, Simonson D: Current concepts: assessment of quality of life outcomes. N Engl J Med 1996, 334:835-840.
17. McHorney CA: Health status assessment methods for adults: past accomplishments and future challenges. Annu Rev Public Health 1999, 20:309-335.
18. Andresen EM, Catlin TK, Wyrwich KW, Jackson-Thompson J: Retest reliability of surveillance questions on health related quality of life. J Epidemiol Community Health 2003, 57:339-343.
19. Newschaffer CJ: Validation of Behavioral Risk Factor Surveillance System (BRFSS) HRQOL measures in a statewide sample. Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 1998.
20. Currey SS, Rao JK, Winfield JB, Callahan LF: Performance of a generic health-related quality of life measure in a clinic population with rheumatic disease. Arthritis Care and Research 2003, 49(5):658-664.
21. Keller HH, Østbye T, Goy R: Nutritional risk predicts quality of life in elderly community-living Canadians. J Gerontol A Biol Sci Med Sci 2004, 59A(1):68-74.
22. Ôunpuu S, Chambers LW, Patterson C, Chan D, Yusuf S: Validity of the U.S. Behavioral Risk Factor Surveillance System's health related quality of life survey in a group of older Canadians. Chronic Diseases in Canada 2001, 22(3-4):93-101.
23. Hennessy CH, Moriarty DG, Zack MM, Scherr PA, Brackbill R: Measuring health-related quality of life for public health surveillance. Public Health Rep 1994, 109(5):665-672.
24. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997, 127(8 Pt 2):757-763.
25. Rosenbaum PR: Observational Studies, Second edn. New York: Springer-Verlag; 2002.
26. D'Agostino R, B., Jr.: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998, 17:2265-2281.
27. %MATCH (a SAS macro to match cases with controls) [http://www.mayo.edu/hsr/sasmac.html]
28. Gorsuch RL: Factor Analysis, Second edn. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1983.
29. Hatcher L: A Step-by-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modeling. Cary, North Carolina: SAS Institute Inc.; 1994.
30. Vickers AJ, Altman DG: Analysing controlled trials with baseline and follow up measurements. BMJ 2001, 323:1123-1124.
31. Avis NE, Crawford S, Stellato R, Longcope C: Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001, 4:243-249.
32. Dominick KL, Ahern FM, Gold CH, Heller DA: Relationship of health-related quality of life to health care utilization and mortality among older adults. Aging Clin Exp Res 2002, 14(6):499-508.
33. Banks E, Beral V, Reeves G, Balkwill A, Barnes I: Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA 2004, 291(18):2212-2220.
34. Yates J, Barrett-Connor E, Barlas S, Chen Y-T, Miller PD, Siris ES: Rapid loss of hip fracture prevention after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Obstet Gynecol 2004, 103(3):440-446.
35. Rothman KJ, Greenland S: Modern Epidemiology, Second edn. Philadelphia: Lippincott-Raven; 1998.
36. Brownley KA, Hinderliter AL, West SG, Grewen KM, Steege JF, Girdler SS, Light KC: Cardiovascular effects of 6 months of hormone replacement versus placebo: differences associated with years since menopause. Am J Obstet Gynecol 2004, 190:1052-1058.
37. Savonenko AV, Markowska AL: The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 2003, 2003:821-830.
38. Nelson HD: Assessing benefits and harms of hormone replacement therapy. JAMA 2002, 288(7):882-884.
39. Grady D: A 60-year-old woman trying to discontinue hormone replacement therapy. JAMA 2002, 287(16):2130-2137.